POTS, or postural orthostatic tachycardia syndrome, has emerged as one of the most recognizable complications of long COVID, affecting roughly a third of the most symptomatic long COVID patients in clinical studies.1PubMed. Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID The condition causes your heart rate to spike when you stand up, often alongside dizziness, brain fog, and crushing fatigue. While POTS existed well before the pandemic, the sheer number of COVID infections worldwide has created a wave of new cases and pushed the condition into mainstream medical awareness.
What POTS Feels Like and How It Gets Diagnosed
POTS is defined by a sustained heart rate increase of at least 30 beats per minute (or over 120 beats per minute total) within ten minutes of standing, without a significant drop in blood pressure. That might sound like a simple measurement, but the symptoms it produces are anything but simple. People with post-COVID POTS commonly report lightheadedness, heart pounding, exercise intolerance, nausea, trembling, and a foggy feeling that makes concentration difficult. Many describe standing in a grocery store line or taking a shower as unexpectedly exhausting.
The diagnostic process typically starts with a straightforward active standing test or a tilt table test, where you’re strapped to a table that tilts you upright while clinicians measure heart rate and blood pressure. In one study comparing long COVID patients with recovered controls, heart rate during tilt was about 8 beats per minute higher throughout the test in the long COVID group, and the majority of them experienced symptoms during tilting, while none of the recovered participants did.2PubMed Central. Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing Autonomic symptom questionnaires like the COMPASS-31 also help quantify the burden. Post-COVID patients in one observational study had median scores around 17 to 18 on this scale, with the worst-affected areas being the ability to stand upright, sweating regulation, gut function, and pupil control.3PubMed Central. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study
How Common Is POTS in Long COVID
Prevalence numbers depend heavily on which patients you’re looking at. In a study of highly symptomatic long COVID patients referred to a specialized clinic, about 31% met the formal criteria for POTS, another 27% had some signs of autonomic trouble without meeting the full threshold, and the remaining 42% had no clinical signs of it.1PubMed. Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID Among people who develop long COVID symptoms more broadly, the rate appears lower. One study comparing post-COVID patients with people diagnosed with ME/CFS found POTS in about 14% of the post-COVID group, compared to 31% of ME/CFS patients.4PubMed Central. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome So the range is wide, depending on how sick the population already is when they walk through the door.
The broader point is that COVID created a large enough surge in POTS cases to reshape the clinical landscape. Before the pandemic, POTS was often dismissed or misdiagnosed, sometimes for years. The post-COVID wave forced many more clinicians to learn about it, which has been a mixed blessing: more recognition, but also overwhelmed specialty clinics and long wait times.
Does Post-COVID POTS Differ from Other Forms
A reasonable question is whether POTS triggered by COVID is fundamentally different from POTS that develops after other infections, surgeries, or without a clear trigger. The current evidence suggests it is not. A physician chart audit comparing POTS patients diagnosed before and after COVID found that while post-COVID patients tended to be somewhat older and had fewer pre-existing conditions, the differences were not clinically meaningful. The diagnostic workup, management approach, and treatment patterns looked similar across both groups.5PubMed. Characterisation of Postural Orthostatic Tachycardia Syndrome (POTS): Findings from a physician chart-audit pre- and post-COVID-19
Deeper physiological testing tells a comparable story. A preprint studying long-COVID POTS in detail found that about 43% of these patients had hyperadrenergic responses during tilt testing (meaning their bodies were flooding the system with adrenaline-like signals). But when researchers compared them to non-COVID POTS patients and healthy controls, the average norepinephrine levels and rates of nerve fiber damage were similar across groups.6medRxiv. Deep Phenotyping Long-COVID Postural Tachycardia Syndrome In other words, COVID seems to be a particularly effective trigger for POTS, but the disease it produces looks a lot like POTS from other causes.
Why COVID Triggers Autonomic Dysfunction
No single mechanism explains all post-COVID POTS. The best current understanding is that several processes can contribute, sometimes simultaneously, and different patients may have different combinations.
Autoantibodies Disrupting the Nervous System
One of the strongest lines of evidence involves autoantibodies, immune proteins that mistakenly target the body’s own tissues. In patients with long COVID and POTS, researchers have found antibodies that react to receptors on blood vessels and the heart. Specifically, antibodies targeting adrenergic receptors (the receptors that adrenaline acts on) can interfere with the normal tightening of blood vessels when you stand, leading to blood pooling in the legs. They can also directly speed up the heart rate.7PubMed Central. Autoimmunity in Long Covid and POTS In one study of 31 recovered COVID patients, every single one had between two and seven different types of these functional autoantibodies. Almost all had antibodies targeting the beta-2 adrenergic receptor and the muscarinic M2 receptor, and about 90% had antibodies targeting components of the renin-angiotensin system, which regulates blood pressure.8Journal of Translational Autoimmunity. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
The picture is not entirely clear-cut. Some of these autoantibodies also appear at low levels in healthy people and may be part of normal immune regulation. The theory is that COVID disrupts the balance, pushing autoantibody levels or activity past the point where they cause harm.9Annals of Allergy, Asthma & Immunology. POTS After COVID: Insights into Post-Viral Autonomic Issues This autoimmune angle is one reason researchers are investigating immunoglobulin therapy and other immune-modulating treatments.
Small Fiber Neuropathy
Another mechanism involves damage to the small nerve fibers that control involuntary functions like blood vessel tone, sweating, and heart rate. This condition, called small fiber neuropathy, has been found in a subset of post-COVID POTS patients. A systematic review found compelling evidence that COVID can both worsen pre-existing small fiber neuropathy and trigger it from scratch, often starting with burning pain and numbness in the hands and feet alongside broader autonomic symptoms.10PubMed Central. Post-COVID-19 Small Fiber Neuropathy as a New Emerging Quality of Life-Threatening Disease: A Systematic Review In the deep-phenotyping preprint, about 12% of long-COVID POTS patients had reduced nerve fiber density on skin biopsy, and nearly 40% showed abnormal sweat gland function, which is another marker of small fiber involvement.6medRxiv. Deep Phenotyping Long-COVID Postural Tachycardia Syndrome
Microclots and Impaired Blood Flow
A more recent hypothesis focuses on tiny, abnormally resistant blood clots that have been found in long COVID patients. These “fibrinaloid microclots” can block capillaries and reduce oxygen delivery to tissues. The argument is that when your tissues become mildly oxygen-starved, the body compensates by ramping up heart rate, and this response becomes exaggerated when you stand because gravity pulls blood away from the brain and toward the legs.11PubMed Central. Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID Supporting this idea, multi-omic profiling of post-COVID POTS patients found that proteins involved in clotting, like plasminogen activator inhibitor 1, were strongly upregulated, implying a state of increased clotting susceptibility.12Scientific Reports. Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study Whether microclots are a cause of POTS or a parallel consequence of the same underlying inflammation remains an active question.
The Overlap with ME/CFS and Post-Viral Syndromes
If you’ve been reading about long COVID, you’ve probably noticed that the symptom lists for POTS, long COVID, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) overlap to a striking degree. All three feature persistent fatigue, cognitive problems, disrupted sleep, post-exertional malaise (where activity makes things worse for days afterward), and orthostatic intolerance.13PubMed Central. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature This overlap is not a coincidence. ME/CFS has long been recognized as a condition that can follow a wide variety of infections, and researchers now see long COVID as the latest entry in this pattern of post-infectious illness.14PubMed Central. Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS
The relationship matters practically because it means that POTS does not exist in isolation for most post-COVID patients. Treating the heart rate issue alone often does not resolve the fatigue, the brain fog, or the exercise intolerance. These overlapping conditions appear to share some of the same biological abnormalities, including immune dysregulation, neuroinflammation, and autonomic dysfunction, even if researchers have not yet untangled exactly how they connect.
Who Is at Greater Risk
One emerging idea is that POTS after COVID may require a “two-hit” process: a pre-existing vulnerability in the autonomic nervous system, followed by the immune disruption of a SARS-CoV-2 infection that tips the system into dysfunction.15PubMed Central. A MULTI-HIT MODEL OF LONG COVID PATHOPHYSIOLOGY: THE INTERACTION BETWEEN IMMUNE TRIGGERS AND NERVOUS SYSTEM SIGNALING Supporting this, up to a third of patients who develop autonomic dysfunction after COVID had some type of cardiovascular or pulmonary abnormality before their infection, potentially lowering the threshold needed for the virus to trigger an autoimmune or inflammatory cascade.16PubMed Central. Narrative Review of Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies
Even the initial severity of the COVID infection does not predict who will develop POTS. People with mild infections that never required hospitalization can still end up with chronic autonomic impairment.14PubMed Central. Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS This is one of the aspects that makes the condition so unsettling: there is no reliable way to look at someone’s acute illness and know whether POTS is coming months later. The condition also affects adolescents, with case series documenting it in patients as young as 11.17AAP Publications / Pediatrics. Ongoing Dizziness Following Acute COVID-19 Infection: A Single Center Pediatric Case Series
Managing Post-COVID POTS
Treatment for post-COVID POTS follows the same general playbook as POTS from other causes, starting with lifestyle changes and adding medications when needed.
Lifestyle and Physical Strategies
The first-line approach involves boosting blood volume and reducing blood pooling. In practice, this means increasing fluid and salt intake (often substantially more than you’d think reasonable), wearing compression garments on the legs and abdomen, and learning physical counter-maneuvers like crossing your legs and tensing your muscles when you feel lightheaded. Avoiding triggers like heat, alcohol, caffeine, and prolonged standing also helps manage day-to-day symptoms.18PubMed Central. Postural orthostatic tachycardia syndrome and post-acute COVID-19
Exercise is an important piece of long-term recovery, but it needs to be approached cautiously. Because upright exercise can provoke symptoms, the standard recommendation is to begin with recumbent activities like swimming, rowing, or using a reclined bike, then gradually progress toward upright exercise over a period of months. A structured, progressive three-month exercise program has been shown to reduce standing heart rate and improve symptoms in POTS patients.18PubMed Central. Postural orthostatic tachycardia syndrome and post-acute COVID-19 The key word is “progressive.” Jumping into an ambitious workout routine too early often backfires, especially in patients who also have post-exertional malaise.
Medications
When lifestyle adjustments are not enough, several medications can help. Ivabradine, a drug that slows heart rate without affecting blood pressure, has shown particular promise for post-COVID POTS. In one prospective study, about 78% of patients reported significant improvement within a week of starting ivabradine, with meaningful reductions in heart rate across 24-hour monitoring.19PubMed Central. Ivabradine effects on COVID-19-associated postural orthostatic tachycardia syndrome: a single center prospective study Other commonly used medications include beta-blockers (low doses to slow the heart), fludrocortisone (to expand blood volume), midodrine (to tighten blood vessels), and pyridostigmine (to improve nerve signaling at the autonomic junction). The choice depends on each patient’s particular symptom profile and which hemodynamic pattern their POTS falls into.
For patients whose POTS appears to be driven by autoimmune mechanisms and who do not respond to standard treatments, more aggressive immune therapies are being explored. Case reports and small case series suggest that intravenous immunoglobulin, plasmapheresis, corticosteroids, and rituximab may help some patients with severe, treatment-resistant POTS.20PubMed Central. Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction These remain experimental and are typically reserved for the most debilitated patients. A major NIH-funded platform trial, RECOVER-AUTONOMIC, is now formally testing coordinated non-drug care, intravenous immunoglobulin, and ivabradine head-to-head in long COVID POTS patients, which should provide much stronger evidence about what actually works.21PubMed. Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome
Recovery Trajectory
One of the hardest questions for patients is whether post-COVID POTS will get better. The honest answer is that many people do improve, but the timeline is unpredictable, and full resolution is not guaranteed. A case series following post-COVID POTS patients over several months found that heart rate responses improved and functional status got better: more patients were able to return to work or school by the end of follow-up compared to their first visit.22PubMed Central. Treatment of long COVID complicated by postural orthostatic tachycardia syndrome—Case series research But “improvement” in these studies often means going from bedridden to functional with accommodations, not a clean return to how things were before.
The economic impact of prolonged illness is substantial. POTS, even outside the COVID context, is associated with significant employment and economic loss, with many patients unable to maintain their pre-illness jobs or forced to reduce their hours drastically.23PubMed Central. Postural orthostatic tachycardia syndrome is associated with significant employment and economic loss For people who developed POTS after COVID, this often comes on top of weeks or months already lost to acute illness and initial recovery. The gap between “medically stable” and “able to work full-time” can be enormous.
Remote Monitoring and the Role of Wearables
Because POTS symptoms fluctuate day to day and can be hard to capture in a brief clinic visit, there is growing interest in using consumer wearable devices for ongoing monitoring. Smartwatches that record heart rate and even basic ECG data can potentially track how a patient’s autonomic function changes over time without requiring repeated trips to a tilt table. A case report demonstrated that posture-based heart rate testing done at home with a smartwatch could capture meaningful changes in autonomic function as a long COVID patient recovered, including improvements in heart rate variability that correlated with clinical improvement.24PubMed Central. Monitoring of cardiorespiratory vagal desynchrony using novel biomarkers derived from smartwatch electrocardiograms in a patient recovering from long COVID: case report
This approach is not ready to replace formal diagnostic testing, but it addresses a real practical gap. Many POTS patients live far from specialty clinics, and their symptoms are often worst on the days they cannot make it to an appointment. A standardized at-home protocol using a smartwatch could help clinicians make treatment decisions between visits. In pediatric patients, where tilt table testing can feel intimidating, simple active standing tests with wearable monitoring may also prove useful for tracking progress over time without repeated clinic visits.